Dr Sergi Alonso
Postdoctoral Researcher
I am a health economist with interests in evaluating and improving access to effective infectious diseases interventions in low- and middle-income countries. I obtained my PhD at the University of Barcelona in 2018 for my work undertaken at the Barcelona Institute for Global Health (ISGlobal). From 2015-2018 I relocated to the Manhiça Health Research Centre (CISM) in Mozambique to further develop my skills and understanding of research in the sub-Saharan African context.
I have evaluated the market for antimalarial medicines in Manhiça (Mozambique) through contingent valuation methods, assessed inequalities and inequities in the delivery of health services, conducted cost-of-illness studies and economic evaluations of complex health intervention; such as the implementation of vector control strategies for malaria, or the adoption of new diagnostic tools and treatment regimens for visceral leishmaniasis in Morocco. After obtaining my PhD I worked for the Institute of Population Health Sciences (IPHS) at Queen Mary University of London, where I evaluated the health and economic impact of public health interventions in the UK.
I joined the Lamberton lab in January 2021 as part of a multidisciplinary team working on mathematical modelling for schistosomiasis. I have analysed the effect of Schistosoma infection and related morbidity on health-related quality of life. I am currently studying behavioural factors contributing to disease transmission by: (i) measuring trust in the healthcare system in Cameroon as a way to improve treatment compliance, and (ii) analysing household cooperation to deploy communal latrines in rural Uganda for disease prevention.
Email: sergi.alonso@glasgow.ac.uk
Research Gate: Sergi Alonso
Linkedin: Sergi Alonso
ORCID: 0000-0001-6664-3736
Publications
Janoušková E, Clark J, Kajero O, Alonso S, Lamberton PHL, Betson M, Prada JM. 2022. Public health policy pillars for the sustainable elimination of zoonotic schistosomiasis. Frontiers in Tropical Medicine 3:826501.
Alonso S, Zulliger R, et al. Cost and cost-effectiveness of indoor residual spraying with pirimiphos-methyl in a high malaria transmission district of Mozambique with high access to standard insecticide-treated nets. Malaria Journal 2021, 20:143. DOI: 10.1186/s12936-021-03687-1.
Alonso S, Kent S, Cobiac L, et al. Impact of the 2003-2018 population salt reduction programme in England: a modelling study. Hypertension. 2021, 77:1086–1094. DOI: 10.1161/HYPERTENSIONAHA.120.16649.
Cirera L, Galata B, Alonso S, et al. Moving towards malaria elimination in southern Mozambique: Cost and cost- effectiveness of mass drug administration combined with intensified malaria control. PLoS ONE 2020, 15: e0235631. DOI: 10.1371/journal.pone.0235631.
Alonso S, Chaccour C, et al. The economic burden of malaria on households and the health system in a high transmission district of Mozambique. Malaria Journal 2019, 18:360. DOI: 10.1186/s12936-019-2995-4.
Alonso S, Cambaco O, et al. Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in Southern Mozambique. BMC Public Health 2019 19:1031. DOI: 10.1186/s12889-019-7338-4.
Sicuri E, Bacoum F, Nonvignon J, Alonso S, et al. The costs of implementing vaccination with the RTS,S malaria vaccine in five sub-Saharan African countries. MDM Policy & Practice 2019, 4:2381468319896280. DOI: 10.1177/2381468319896280.
Chaccour C*, Alonso S*, Zulliger R*, et al. Combination of long-lasting insecticide-treated nets with indoor residual spraying for malaria control in Zambezia, Mozambique: a cluster-randomized trial study protocol. BMJ Global Health 2018, 3:e000610. DOI: 10.1136/bmjgh-2017-000610. *Equal contributors.
Sicuri E, Bardaji A, Sanz S, Alonso S, et al. Patients’ costs, socio-economic and health system aspects associated with malaria in pregnancy in an endemic area of Colombia. PLOS NTDs 2018, 12:e0006431. DOI: 10.1371/journal.pntd.0006431.
Alonso S, Munguambe K, Sicuri E. Market for Artemether-Lumefantrine to treat childhood malaria in a district of Southern Mozambique. Health Economics 2017, 26:345-360. DOI: 10.1002/hec.3514.
Alonso S, Tachfouti N, et al. Cost-effectiveness of diagnostic-therapeutic strategies for pediatric Visceral Leishmaniasis in Morocco. BMJ Global Health 2017, 2:e000315. DOI: 10.1136/ bmjgh-2017-000315.
Tachfouti N, Najdi A, Alonso S, et al. Cost of pediatric Visceral Leishmaniasis Care in Morocco. PLOS One 2016, 11:e0155482. DOI: 10.1371/journal. pone.0155482.
Pastor L, Casellas A, Carrillo J, Alonso S, et al. Plasma IP-10 Levels as a Powerful Tool to Detect Acute HIV Infection in Patients with Undifferentiated Fever. Scientific Reports 2017, 7:8104. DOI: 10.1038/s41598-017-08218-0.